ET
IONS icon

Entropy Technologies’s Ionis Pharmaceuticals IONS Stock Holding History

Entropy Technologies’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
36,815
+9,608
+35% +$723K 0.12% 250
2026
Q1 		$2.04M Buy
+27,207
New +$2.15M 0.09% 280
2025
Q4 		– Sell
-32,925
Closed -$2.15M – 1019
2025
Q3 		$2.15M Buy
32,925
+3,473
+12% +$170K 0.16% 175
2025
Q2 		$1.16M Buy
+29,452
New +$964K 0.09% 277
2024
Q2 		– Sell
-14,542
Closed -$630K – 808
2024
Q1 		$630K Buy
+14,542
New +$693K 0.07% 382

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Entropy Technologies's IONS Position: Q2 2026 in Review

Entropy Technologies increased its Ionis Pharmaceuticals (IONS) stake by 35% in Q2 2026, buying an estimated $723K and bringing the position to 36,815 shares worth $2.92M. The position accounts for 0.12% of the portfolio, ranked #250.

Entropy Technologies first reported a position in IONS in Q1 2024 and has held it in 5 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Entropy Technologies held 36,815 shares of Ionis Pharmaceuticals worth $2.92M as of Q2 2026.
  • Entropy Technologies bought 9,608 Ionis Pharmaceuticals shares in Q2 2026, an estimated $723K.
  • Ionis Pharmaceuticals made up 0.12% of Entropy Technologies's portfolio in Q2 2026, its #250 holding.
  • Entropy Technologies first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.